SMARCA5 and prostate carcinoma: Our data perhaps suggest in RC43N, there is an 1α,25(OH)2D3-autoregulatory mechanism for BAZ1A/SMARCA5 expression and this function that is corrupted in RC43T, and AA prostate cancer.